- Home
- ALZN vs INBS Comparison
ALZN vs INBS Comparison
Compare ALZN & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- INBS
- Stock Information
- Founded
- ALZN 2016
- INBS 2016
- Country
- ALZN United States
- INBS United States
- Employees
- ALZN N/A
- INBS N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- INBS Medical Specialities
- Sector
- ALZN Health Care
- INBS Health Care
- Exchange
- ALZN Nasdaq
- INBS Nasdaq
- Market Cap
- ALZN 7.0M
- INBS 6.3M
- IPO Year
- ALZN 2021
- INBS N/A
- Fundamental
- Price
- ALZN $1.11
- INBS $1.30
- Analyst Decision
- ALZN Strong Buy
- INBS
- Analyst Count
- ALZN 1
- INBS 0
- Target Price
- ALZN $32.00
- INBS N/A
- AVG Volume (30 Days)
- ALZN 174.7K
- INBS 132.7K
- Earning Date
- ALZN 12-31-2024
- INBS 02-07-2025
- Dividend Yield
- ALZN N/A
- INBS N/A
- EPS Growth
- ALZN N/A
- INBS N/A
- EPS
- ALZN N/A
- INBS N/A
- Revenue
- ALZN N/A
- INBS $3,187,974.00
- Revenue This Year
- ALZN N/A
- INBS $280.88
- Revenue Next Year
- ALZN N/A
- INBS $126.26
- P/E Ratio
- ALZN N/A
- INBS N/A
- Revenue Growth
- ALZN N/A
- INBS 55.29
- 52 Week Low
- ALZN $1.06
- INBS $1.00
- 52 Week High
- ALZN $15.06
- INBS $11.70
- Technical
- Relative Strength Index (RSI)
- ALZN 34.55
- INBS 36.48
- Support Level
- ALZN $1.16
- INBS $1.20
- Resistance Level
- ALZN $1.33
- INBS $1.69
- Average True Range (ATR)
- ALZN 0.09
- INBS 0.12
- MACD
- ALZN 0.01
- INBS -0.04
- Stochastic Oscillator
- ALZN 17.86
- INBS 19.61
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).